Janssen Search
Search results
Janssen Provides Portfolio Update
Mar 29, 2023 United States RARITAN, N.J., March 29, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson disclosed today that following a review of its portfolio to prioritize the most transformational assets for ongoing investment, and an ...
John C. Reed, M.D., Ph.D.
JOHN C. REED, M.D., PH.D. EXECUTIVE VICE PRESIDENT PHARMACEUTICALS, R&D JOHNSON & JOHNSON As Executive Vice President, Pharmaceuticals, R&D and Johnson & Johnson (J&J) Executive Committee member, John’s mission is to focus the best ...
PH Development
Development Investing in ways to improve the diagnosis gap and improve survival rates. At Janssen, we are committed to addressing the diagnostic gap and improving survival rates. We have undertaken extensive research to map out the patient journey in ...
PH Discovery
Discovery Initiating a new age of pulmonary hypertension (PH) research to address unmet needs in the patient journey. We are initiating a new age of pulmonary hypertension (PH) research by holistically addressing unmet needs across the patient journey. ...
Janssen Human Microbiome Institute
Unlocking the Microbiome to Find Breakthrough Solutions That Promote Health Our focus is on accelerating the translation of the compelling science of the microbiome into breakthrough solutions that promote health. To achieve this, we are partnering with ...
Jen Beachell
JEN BEACHELL VICE PRESIDENT DISEASE AREA COMMERCIAL LEADER AUTOANTIBODY Jennifer Beachell is Vice President, Disease Area Commercial Leader, Autoantibody, within the Immunology Therapeutic Area at Janssen Research & Development, LLC. In this role, Jen ...
Janssen Showcases Support for Patients This World Lupus Day
Supporting Patients on World Lupus Day and Every Day On May 10, we recognize World Lupus Day by remaining committed to deepening our understanding of lupus, a complex and often misdiagnosed disease affecting more than five million people worldwide. ...
Clinical Trial Diversity
Clinical Trial Diversity: Putting Thought to Action to Develop Sustainable Improvements The lack of diversity in clinical trials has been recognized as a major impediment to healthcare equality for decades. Unfortunately, attempts to increase ...
Contact Us – Oncology
Contact Oncology at Janssen Apr 02, 2015 Thank you for your interest in learning more about our company. Interested in a potential collaboration with Janssen? Contact us with your idea. If you are a member of the media, and need to reach our Research & ...
At Risk for Alzheimer’s disease?
Article Block Text: Article Type: Janssen Prevention Center At Risk for Alzheimer’s disease? Scientists at the Janssen Prevention Center have published their research into potential biomarkers of risk for Alzheimer’s disease, the most common form of ...